NOD2 Transgenic Mice Exhibit Enhanced MDP-Mediated Down-Regulation of TLR2 Responses and Resistance to Colitis Induction
- 1 November 2007
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 133 (5) , 1510-1521
- https://doi.org/10.1053/j.gastro.2007.07.025
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Signalling pathways and molecular interactions of NOD1 and NOD2Nature Reviews Immunology, 2005
- Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF- B decoy oligonucleotidesJournal of Clinical Investigation, 2005
- Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's diseaseThe Lancet, 2005
- Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal TractScience, 2005
- The Crohn's Disease Protein, NOD2, Requires RIP2 in Order to Induce Ubiquitinylation of a Novel Site on NEMOCurrent Biology, 2004
- The immunological and genetic basis of inflammatory bowel diseaseNature Reviews Immunology, 2003
- NODs: intracellular proteins involved in inflammation and apoptosisNature Reviews Immunology, 2003
- Host Recognition of Bacterial Muramyl Dipeptide Mediated through NOD2Journal of Biological Chemistry, 2003
- The Immunology of Mucosal Models of InflammationAnnual Review of Immunology, 2002
- Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κBJournal of Biological Chemistry, 2001